2023-11-20 LivaNova PLC Cybersecurity Incident

Page last updated on April 11, 2024

LivaNova PLC initially disclosed a cybersecurity incident in an SEC 8-K filing on 2023-11-20 17:15:35 EST.

Company Summary

LivaNova, PLC is an American medical device manufacturer domiciled in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol “LIVN”.
Source: Wikipedia

Incident Details

Material: Unknown
Is Breach: Unknown
Records Compromised: Unknown
Data Types Impacted: No Data Types Tracked (yet)

Compromised Date:
Detected Date:
Disclosure Date: 2023-11-20
Contained Date:
Recovered Date:

Attack Goal: Unknown

Costs: No Costs Tracked (yet)

Filings

8-K filed on 2023-11-20

LivaNova PLC filed an 8-K at 2023-11-20 17:15:35 EST
Accession Number: 0001104659-23-119971

Item 8.01 Other Events.

LivaNova PLC (the “Company”) has detected a cybersecurity incident that has resulted in a disruption of portions of its information technology systems. Promptly after detecting the issue, the Company began an investigation with assistance from external cybersecurity experts and is coordinating with law forcement. The Company continues to assess what information and systems were impacted and is executing its incident response plan, including implementing remediation measures to mitigate the impact of the incident. The Company has and will continue to take actions to remediate the issue, such as taking certain systems offline. The incident, however, has caused, and is expected to continue to cause, disruption to parts of the Company’s business operations. The Company cannot determine at this time the extent of the impact from such event on its business, results of operations, cash flows or financial condition.

8-K filed on 2023-12-06

LivaNova PLC filed an 8-K at 2023-12-06 07:00:21 EST
Accession Number: 0001104659-23-123806

Item 8.01 Other Events.

On December 6 and 7, 2023, executives of LivaNova PLC (the “Company”) will attend the Mizuho Medical Device & Healthcare Services Summit and Wolfe Research investor meetings. During these meetings, the Company expects to provide an update on operations with respect to the cybersecurity incident previously disclosed on November 20, 2023, as follows.
The Company successfully executed a soft launch at its sites in the United States. These sites are now substantially operating at normal levels. In addition, the Company has begun executing a soft launch with respect to its manufacturing sites in Europe, though it may take longer for the Company’s European manufacturing sites to reach normal levels of operations compared to the Company’s U.S. sites.

8-K filed on 2023-12-13

LivaNova PLC filed an 8-K at 2023-12-13 08:30:23 EST
Accession Number: 0001104659-23-125585

Item 8.01 Other Events.

LivaNova PLC (the “Company”) is providing an update on operations with respect to the cybersecurity incident initially disclosed on November 20, 2023. At this time, all of the Company’s manufacturing sites worldwide are substantially operating at normal levels. As previously disclosed, promptly after detecting the cybersecurity issue, the Company began an investigation with assistance from external cybersecurity experts and coordinated with law forcement. The Company took certain actions to remediate the issue, such as taking certain systems offline. Due to these and other measures, the Company believes it has contained the cybersecurity threat though its investigation and mitigation efforts are ongoing. The Company continues to assess the full impact of the cybersecurity event on its business, results of operations, cash flows and financial condition.

Company Information